Deep learning—a form of artificial intelligence capable of improving itself with limited user input—has radically reshaped the landscape of biomedical research since its emergence in the early 2010s.

TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today the release of the manuscript, “An RNA ...

Artificial intelligence (AI) machine learning is rapidly emerging as a powerful tool in the quest for novel diagnostics, therapies, and treatment for complex diseases such as cancer. Increasingly, ...

TORONTO--(BUSINESS WIRE)--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation ...

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Advances in artificial intelligence (AI) deep learning, genomics, and computing hardware is accelerating life sciences research and discovery. In a new study published today in Nature Communications, ...

TORONTO, Dec. 2, 2025 /PRNewswire/ -- Katalyze AI today announced the appointment of Hannes Bretschneider as Chief AI Officer. Hannes will lead the development of Agentic AI architecture and expand ...